The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction

This publication has 79 references indexed in Scilit:

• Phenotypic Switching ofCryptococcus neoformansCan Produce Variants That Elicit Increased Intracranial Pressure in a Rat Model of Cryptococcal Meningoencephalitis
  Infection and Immunity, 2005
• Capsule Structure Changes Associated with Cryptococcus neoformans Crossing of the Blood-Brain Barrier
  The American Journal of Pathology, 2005
• Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans , Inhibits the Progression of Group B Streptococcal Arthritis
  Infection and Immunity, 2004
• Cavitating pneumonia after treatment with infliximab and prednisone
  European Journal of Clinical Microbiology & Infectious Diseases, 2004
• Molecular architecture of the Cryptococcus neoformans capsule
  Molecular Microbiology, 2004
• Mass Spectrometric Composition and Molecular Mass ofLumbricus terrestrisHemoglobin: A Refined Model of its Quaternary Structure
  Journal of Molecular Biology, 1996
• Antibodies Elicited by a Cryptococcus neoformans-Tetanus Toxoid Conjugate Vaccine Have the Same Specificity as Those Elicited in Infection
  The Journal of Infectious Diseases, 1992
• The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies.
  The Journal of Experimental Medicine, 1991
• Definitions of terms relating to individual macromolecules, their assemblies, and dilute polymer solutions (Recommendations 1988)
  Pure and Applied Chemistry, 1989
• Natural Host Resistance to Infection with Cryptococcus Neoformans: III. The Effect of Cryptococcal Polysaccharide upon the Physiology of the Reticuloendothelial System of Laboratory Animals
  The Journal of Infectious Diseases, 1964